Century Therapeutics (IPSC) Depreciation and Depletion (2020 - 2026)
Century Therapeutics (IPSC) posted quarterly Depreciation and Depletion of $3.0 million for Q1 2026, down 6.74% year-over-year from $3.2 million in Q1 2025, and down 15.38% quarter-over-quarter from $3.6 million in Q4 2025.
Century Therapeutics (IPSC) Depreciation and Depletion (2020 - 2026) Analysis & Trends
Century Therapeutics (IPSC) has reported Depreciation and Depletion for 7 consecutive years, with $3.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Depreciation and Depletion fell 6.74% year-over-year to $3.0 million; the TTM figure through Mar 2026 stood at $12.9 million (down 3.11% YoY), while the FY2025 annual figure was $13.1 million, down 1.53% from the prior year.
- Depreciation and Depletion declined to $3.0 million in Q1 2026 per IPSC's latest filing, from $3.6 million in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $3.6 million in Q4 2023 and bottomed at $1.2 million in Q1 2022.
- Historically, Depreciation and Depletion has averaged $3.0 million across 5 years, with a median of $3.2 million in 2025.
- Annual changes were most pronounced in 2022 — Depreciation and Depletion soared 170.03% — and 2025, when it dropped 7.54%.
- Century Therapeutics' Depreciation and Depletion stood at $2.8 million in 2022, then climbed by 25.16% to $3.6 million in 2023, then declined by 6.59% to $3.3 million in 2024, then increased by 6.99% to $3.6 million in 2025, then retreated by 15.38% to $3.0 million in 2026.
- Business Quant data shows IPSC's Depreciation and Depletion at $3.0 million in Q1 2026, $3.6 million in Q4 2025, and $3.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.10 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 38.91 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 3.18 Mn |
| 10 | Century Therapeutics | 346.65 Mn | 86.58 Mn | - | 26,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 26,000.00 |
| Jun 30, 2026 | 26,000.00 |
| Mar 31, 2026 | 3.00 Mn |
| Mar 31, 2026 | 3.00 Mn |
| Dec 31, 2025 | 3.55 Mn |
| Dec 31, 2025 | 3.55 Mn |
| Sep 30, 2025 | 3.13 Mn |
| Sep 30, 2025 | 3.13 Mn |
| Jun 30, 2025 | 3.20 Mn |
| Jun 30, 2025 | 3.20 Mn |
| Mar 31, 2025 | 3.22 Mn |
| Mar 31, 2025 | 3.22 Mn |
| Dec 31, 2024 | 3.32 Mn |
| Dec 31, 2024 | 3.32 Mn |
| Sep 30, 2024 | 3.30 Mn |
| Sep 30, 2024 | 3.30 Mn |
| Jun 30, 2024 | 3.46 Mn |
| Jun 30, 2024 | 3.46 Mn |
| Mar 31, 2024 | 3.23 Mn |
| Mar 31, 2024 | 3.23 Mn |